SCHEMBL13820575

SCHEMBL13820575

c1ccc(-c2nc(-c3ccccc3)nc(-c3c4ccccc4c(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4cc5c(cc34)c(-c3ccccc3)c(-c3cccc4ccccc34)c3ccccc35)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 4/20 0.46
MAPK1 P28482 2/20 0.46
HSD17B10 Q99714 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TSHR P16473 2/20 0.46
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
ENPP1 P22413 1/20 0.37
ESR1 P03372 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21416128 0.90 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL17227637 0.86 MAPT (0.54) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL25669063 0.84 MAPT (0.49) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL22766462 0.83 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL22766642 0.83 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL13820567 0.83 MAPT (0.46) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18623324 0.82 ALDH1A1 (0.50) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL21309285 0.82 MAPT (0.53) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL12133924 0.81 ALDH1A1 (0.47) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL12133908 0.81 ALDH1A1 (0.47) MAPTALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, LEF1, OR51E2 MAPT 1302/4885ALDH1A1 20/4885HPGD 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.